Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Three different methods were compared for creating Titan cells, a type of fungus cell. The OZ method made the most cells initially, but the number dropped quickly. The EB method also made a lot of cells, but the number also dropped. The AA method made fewer cells, but the number stayed steady. The methods also affected which genes were active in the cells.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

Finasteride and minoxidil are effective for hair loss, with potential side effects, and JAK inhibitors show promise for alopecia areata.

Lack of sleep in mice leads to prostatitis by reducing certain hormones and activating an inflammatory pathway, which can be temporarily fixed with normal sleep.

Extracellular vesicles show promise as treatments but need more research for safety and effectiveness.

SARS-CoV-2 may worsen IPF due to shared genes and pathways, suggesting potential drug targets.

Testosterone therapy can improve hormone levels and quality of life in men with morphine-induced hormone issues.

Organoid technology helps create mini-organs for studying diseases and testing drugs.

Myricetin shows promise as an anticancer agent by reducing inflammation and enhancing drug effectiveness.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

Low testosterone may indicate severe COVID-19 in men.

Platelet-rich plasma shows promise for treating erectile dysfunction, but more research is needed.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Bubble-based systems show promise for precise, targeted drug delivery and diagnosis, especially in cancer treatment.

Proton minibeam radiotherapy shows promise for sparing healthy tissue in cancer treatment but needs further research and technological development.

Polycystic ovary syndrome (PCOS) was first described in 1721, officially diagnosed in the 1990s, and is now known to be partly genetic and linked to insulin resistance, with increased risk of cardiovascular disease and carbohydrate metabolism issues.

Single-cell transcriptomics helps improve animal health and productivity by studying gene expression in individual cells.

The new drug delivery system effectively targets lung cancer cells.

Trichilemmal carcinoma shares genetic changes with other skin cancers, suggesting similar causes and potential treatments.

Researchers created a rat model to study skin damage caused by radiation, which could help develop new treatments.

Lower testosterone levels may increase heart failure risk in older men.

PP2Acα is essential for proper hair and skin development.

The compounds tested could potentially treat hair loss and alopecia.

MX1 and AR genes are linked to milder COVID-19, while TMPRSS2 increases severe risk, especially in women.

β-Sitosterol may help prevent heart disease, cancer, and diabetes, but more human studies are needed.

Guava leaf extract may help treat hair loss and protect cells by blocking certain genes and fighting damaging molecules.

Steroid 5α-reductase evolved from protists and diversified in eukaryotes, with specific roles in mammals and plants.

Tumor proteins can both promote and suppress cancer, depending on the situation.

HER2-targeted or hormonal therapies improve quality of life for Sudanese breast cancer patients.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.